J. Díaz

Spontaneous Hypoglycemia Associated With Autoimmunity Specific to Human Insulin

P. Erb, U. Keller, T. Wilkin, 1987, Diabetes Care.

VALUE OF INSULIN AUTOANTIBODIES AS SERUM MARKERS FOR INSULIN-DEPENDENT DIABETES MELLITUS

D. Pyke, R. Leslie, M. Rodier, 1985, The Lancet.

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

E. Guallar, J. Ordovás, L. Badimón, 2011, Lipids in Health and Disease.

PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.

César Martín, M. Croyal, T. Moyon, 2016, Atherosclerosis.

Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: a randomized trial

J. J. de la Cruz, J. Díaz, J. Haya, 2008, Menopause.

Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®)

D. Ibarretxe, L. Masana, F. Civeira, 2020 .

Screening of APOB Gene Mutations in Subjects with Clinical Diagnosis of Familial Hypercholesterolemia

F. Civeira, E. Martorell, A. Cenarro, 2005, Human biology.

Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®).

D. Ibarretxe, L. Masana, F. Civeira, 2020, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.

César Martín, M. Croyal, T. Moyon, 2016, Atherosclerosis.